Marcie A. Goldstein
Lawyers
Represents broker-dealers and issuers on securities law compliance and FINRA requirements.
Marcie represents broker-dealers and issuers in connection with public and private securities offerings, mergers and other corporate transactions with respect to compliance with state securities laws and FINRA requirements.
Experience highlights
Recent Representations
- Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
- Arrival $300 million at-the-market offering
- TransMedics Group $150 million follow-on offering
- RxSight $50 million at-the-market offering
- Legend Biotech $403 million follow-on offering
- Revolution Medicines $264.5 million follow-on offering
- ChargePoint Holdings $500 million at-the-market offering
- Hennessy Capital Investment VI $300 million IPO
- Gracell Biotechnologies at-the-market offering
- Investcorp India Acquisition $258.8 million IPO
- Hayward Holdings $348 million secondary offering
- HilleVax $200 million IPO
- Krispy Kreme $500 million IPO
- CCC Intelligent Solutions Holdings $194 million follow-on offering
- Excelerate Energy $384 million IPO
- Pegasus Digital Mobility Acquisition $200 million IPO
Insights
Education
J.D., Wayne State University Law School
B.A., University of Michigan
- with honors
Professional history
- Counsel, 1988-present
- Associate, Davis Polk, 1983-1988
- Examiner, Michigan Corporation & Securities Bureau, 1980-1981
- Assistant Director, Corporate Financing, National Association of Securities Dealers, 1982-1983
Qualifications and admissions
- State of New York